iAnthus Capital Holdings, Inc., (CSE: IAN) (CSE: IAN.CN) (CNSX: IAN), announces that it closed its previously announced offering of 7,072,500 common shares of the Company at a price of $1.70 per Common Share for aggregate gross proceeds to the Company of $12,023,250..
Legalizing marijuana nationwide would create at least $132 billion in tax revenue and more than a million new jobs across the United States in the next decade, according to a new study.
PotNetwork Holding, Inc. (OTC: POTN), through wholly-owned subsidiary Diamond CBD, Inc., this morning reported revenues exceeding $1.6 million for the month of November.
In Canada, chronic pain affects 1.5 million people. As national and worldwide numbers in pain diagnoses continue to rise, innovators in the cannabis industry are developing promising therapies to address this growing market.
India Globalization Capital, Inc. (NYSE American: IGC) sees opportunities in 2018, primarily from the distribution, in Germany, of its cannabinoid-based therapies, including IGC-AD1 (Hyalolex).
India Globalization Capital (NYSE American: IGC) today reported financial results for the second quarter ended September 30, 2017, as well as an overview of recent operational highlights.
Aurora Cannabis Inc. (TSX: ACB) announced today that, further to its press release of November 14, 2017, it intends to make an offer to purchase all of the issued and outstanding common shares of CanniMed Therapeutics Inc. (TSX: CMED) for consideration consisting of common shares of Aurora.
Capsules Ready in Time to Supply Pharmacy Joint Initiative in Q1 2018
ChineseInvestors.com (OTCQB: CIIX) said today that its foreign enterprise, CBD Biotechnology Co. Ltd., has partnered with The Godfather of Beauty for the launch of its “CBD Magic Hemp Series” skincare line on China’s largest e-commerce retailer Alibaba.
Canopy Growth Corporation (TSX: WEED) is pleased to welcome Sweetgrass Inc., to Tweed's curated CraftGrow line.
Skinvisible Pharmaceuticals (OTCQB: SKVI) is a topical and transdermal product development company with a proprietary drug delivery system, Invisicare.
InMed will present at the Biopharma Forum on 'Cannabis-Based Science & Medicine' conference on Thursday, November 30th and Friday, December 1st, 2017 in Denver, CO.
Canopy Growth enters into subscription agreements with TerrAscend Corp.
Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) this morning said its Ovation Science subsidiary has reached a licensing agreement with Cannabiniers.
Special Warrants Convert into 6% Unsecured Convertible Debentures at $6.50 Per Common Share
